This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawford, S. E.
Right arrow Articles by Conner, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, S. E.
Right arrow Articles by Conner, M. E.

 Previous Article  |  Next Article 

Journal of Virology, June 1999, p. 4813-4822, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles

Sue E. Crawford,1 Mary K. Estes,1 Max Ciarlet,1 Christopher Barone,1 Christine M. O'Neal,1 Jean Cohen,2 and Margaret E. Conner1,3,*

Division of Molecular Virology, Baylor College of Medicine,1 and Veterans Affairs Medical Center,3 Houston, Texas 77030, and Laboratories de Recherché de Virologie et d'Immunologie Moléculaires, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France2

Received 27 August 1998/Accepted 24 February 1999

The recognition that rotaviruses are the major cause of life-threatening diarrheal disease and significant morbidity in young children has focused efforts on disease prevention and control of these viruses. Although the correlates of protection in children remain unclear, some studies indicate that serotype-specific antibody is important. Based on this premise, current live attenuated reassortant rotavirus vaccines include the four predominant serotypes of virus. We are evaluating subunit rotavirus vaccines, 2/6/7-VLPs and 2/4/6/7-VLPs, that contain only a single VP7 of serotype G1 or G3. In mice immunized parenterally twice, G3 virus-like particles (VLPs) induced a homotypic, whereas G1 VLPs induced a homotypic and heterotypic (G3) serum neutralizing immune response. Administration of three doses of G1 or G3 VLPs induced serum antibodies that neutralized five of seven different serotype test viruses. The inclusion of VP4 in the VLPs was not essential for the induction of heterotypic neutralizing antibody in mice. To confirm these results in another species, rabbits were immunized parenterally with two doses of 2/4/6/7-VLPs containing a G3 or G1 VP7, sequentially with G3 VLPs followed by G1 (G3/G1) VLPs, or with live or psoralen-inactivated SA11. High-titer homotypic serum neutralizing antibody was induced in all rabbits, and low-level heterotypic neutralizing antibody was induced in a subset of rabbits. The rabbits immunized with the G1 or G3/G1 VLPs in QS-21 were challenged orally with live G3 ALA rotavirus. Protection levels were similar in rabbits immunized with homotypic G3 2/4/6/7-VLPs, heterotypic G1 2/4/6/7-VLPs, or G3/G1 2/4/6/7-VLPs. Therefore, G1 2/4/6/7-VLPs can induce protective immunity against a live heterotypic rotavirus challenge in an adjuvant with potential use in humans. Following challenge, broad serum heterotypic neutralizing antibody responses were detected in rabbits parenterally immunized with G1, G3/G1, or G3 VLPs but not with SA11. Immunization with VLPs may provide sufficient priming of the immune system to induce protective anamnestic heterotypic neutralizing antibody responses upon subsequent rotavirus infection. Therefore, a limited number of serotypes of VLPs may be sufficient to provide a broadly protective subunit vaccine.


* Corresponding author. Mailing address: Division of Molecular Virology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-3590. Fax: (713) 798-3586. E-mail: mconner{at}bcm.tmc.edu.


Journal of Virology, June 1999, p. 4813-4822, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Trask, S. D., Dormitzer, P. R. (2006). Assembly of Highly Infectious Rotavirus Particles Recoated with Recombinant Outer Capsid Proteins. J. Virol. 80: 11293-11304 [Abstract] [Full Text]  
  • Azevedo, M. S. P., Yuan, L., Iosef, C., Chang, K.-O., Kim, Y., Van Nguyen, T., Saif, L. J. (2004). Magnitude of Serum and Intestinal Antibody Responses Induced by Sequential Replicating and Nonreplicating Rotavirus Vaccines in Gnotobiotic Pigs and Correlation with Protection. CVI 11: 12-20 [Abstract] [Full Text]  
  • Potgieter, A. C., Steele, A. D., van Dijk, A. A. (2002). Cloning of complete genome sets of six dsRNA viruses using an improved cloning method for large dsRNA genes. J. Gen. Virol. 83: 2215-2223 [Abstract] [Full Text]  
  • Harrington, P. R., Yount, B., Johnston, R. E., Davis, N., Moe, C., Baric, R. S. (2002). Systemic, Mucosal, and Heterotypic Immune Induction in Mice Inoculated with Venezuelan Equine Encephalitis Replicons Expressing Norwalk Virus-Like Particles. J. Virol. 76: 730-742 [Abstract] [Full Text]  
  • Yuan, L., Geyer, A., Hodgins, D. C., Fan, Z., Qian, Y., Chang, K.-O., Crawford, S. E., Parreño, V., Ward, L. A., Estes, M. K., Conner, M. E., Saif, L. J. (2000). Intranasal Administration of 2/6-Rotavirus-Like Particles with Mutant Escherichia coli Heat-Labile Toxin (LT-R192G) Induces Antibody-Secreting Cell Responses but Not Protective Immunity in Gnotobiotic Pigs. J. Virol. 74: 8843-8853 [Abstract] [Full Text]  
  • Ciarlet, M., Estes, M. K., Conner, M. E. (2000). Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits. J. Gen. Virol. 81: 1237-1249 [Abstract] [Full Text]  
  • Al-Yousif, Y., Al-Majhdi, F., Chard-Bergstrom, C., Anderson, J., Kapil, S. (2000). Development, Characterization, and Diagnostic Applications of Monoclonal Antibodies against Bovine Rotavirus. CVI 7: 288-292 [Abstract] [Full Text]